Hogan Lovells advises Valneva on its capital increase
14 June 2013
Valneva, the new fully integrated European biotech company created in 2013 through the merger between Vivalis and Intercell, has announced the launch of a fully underwritten €40 million capital increase with preferential subscription rights.
Hogan Lovells, who has advised Vivalis in relation to its merger with Intercell, also advised Valneva and the Banks on this capital increase. The team in charge of this deal was made up of Jean-Marc Franceschi, Paris Corporate partner, assisted by Thomas Saint-Loubert-Bié, as well as for the tax aspects, Virginie Aïdan, and for the international aspects, John Basnage, London Corporate partner, assisted by Jaime Huertas.
About Hogan Lovells
For more information, see www.hoganlovells.com
Hogan Lovells is a leading global law firm providing business-oriented legal advice and high-quality service across its exceptional breadth of practices to clients around the world.
"Hogan Lovells" or the "firm" is an international legal practice that includes Hogan Lovells International LLP, Hogan Lovells US LLP and their affiliated businesses.
The word "partner" is used to describe a partner or member of Hogan Lovells International LLP, Hogan Lovells US LLP or any of their affiliated entities or any employee or consultant with equivalent standing. Certain individuals, who are designated as partners, but who are not members of Hogan Lovells International LLP, do not hold qualifications equivalent to members.
For more information about Hogan Lovells, the partners and their qualifications, see www.hoganlovells.com.
Where case studies are included, results achieved do not guarantee similar outcomes for other clients.